DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Nitroglycerin

Nitroglycerin

  • Comparison of the Antiischaemic and Antianginal Effects of Nicorandil and Amlodipine in Patients with Symptomatic Stable Angina Pectoris: the SWAN Study

    Comparison of the Antiischaemic and Antianginal Effects of Nicorandil and Amlodipine in Patients with Symptomatic Stable Angina Pectoris: the SWAN Study

  • Nitroglycerin Sublingual Tablets, USP)

    Nitroglycerin Sublingual Tablets, USP)

  • 1 SAFETY DATA SHEET Product Name: Nitroglycerin in 5% Dextrose

    1 SAFETY DATA SHEET Product Name: Nitroglycerin in 5% Dextrose

  • NITROGYLCERIN and ETHYLENE GLYCOL DINITRATE Criteria for a Recommended Standard OCCUPATIONAL EXPOSURE to NITROGLYCERIN and ETHYLENE GLYCOL DINITRATE

    NITROGYLCERIN and ETHYLENE GLYCOL DINITRATE Criteria for a Recommended Standard OCCUPATIONAL EXPOSURE to NITROGLYCERIN and ETHYLENE GLYCOL DINITRATE

  • Sustained Formation of Nitroglycerin-Derived Nitric Oxide

    Sustained Formation of Nitroglycerin-Derived Nitric Oxide

  • Metabolomics-Driven Elucidation of Cellular Nitrate Tolerance Reveals Ascorbic Acid Prevents Nitroglycerin-Induced Inactivation of Xanthine Oxidase

    Metabolomics-Driven Elucidation of Cellular Nitrate Tolerance Reveals Ascorbic Acid Prevents Nitroglycerin-Induced Inactivation of Xanthine Oxidase

  • Original Article Acute Effects of Intracoronary Nicorandil and Nitroglycerin in Patients with Coronary Slow Flow

    Original Article Acute Effects of Intracoronary Nicorandil and Nitroglycerin in Patients with Coronary Slow Flow

  • United States Patent Office Patented Sept

    United States Patent Office Patented Sept

  • An Update on Nitrate Tolerance: Can It Be Avoided? S.R.J

    An Update on Nitrate Tolerance: Can It Be Avoided? S.R.J

  • Nitroglycerin

    Nitroglycerin

  • Tetrahydrobiopterin: a Novel Antihypertensive Therapy

    Tetrahydrobiopterin: a Novel Antihypertensive Therapy

  • PROVISIONAL PEER REVIEWED TOXICITY VALUES for NITROGLYCERIN (CASRN 55-63-0) Derivation of Subchronic and Chronic Oral Rfds

    PROVISIONAL PEER REVIEWED TOXICITY VALUES for NITROGLYCERIN (CASRN 55-63-0) Derivation of Subchronic and Chronic Oral Rfds

  • Nitrostat (Nitroglycerin Sublingual Tablets, USP)

    Nitrostat (Nitroglycerin Sublingual Tablets, USP)

  • United States Patent Office. Wlia

    United States Patent Office. Wlia

  • Nitroglycerin in 5% Dextrose Injection for Intravenous Use Only

    Nitroglycerin in 5% Dextrose Injection for Intravenous Use Only

  • Nitroglycerin

    Nitroglycerin

  • TEGDN, Sensitivity Reducing Ingredient for Nitrocellulose Based Propellants

    TEGDN, Sensitivity Reducing Ingredient for Nitrocellulose Based Propellants

  • Nitroglycerin Ointment

    Nitroglycerin Ointment

Top View
  • Knowing YOUR MEDICATIONS
  • Differential Effects of Pentaerythritol Tetranitrate and Nitroglycerin on The
  • Short Communication EFFECTS of MOLSIDOMINE on CORONARY
  • US5545625.Pdf
  • Page 1 of 18 PRODUCT MONOGRAPH NITROGLYCERIN
  • Nitroglycerin ______
  • Does Nitroglycerin Therapy Hit the Endothelium?
  • Ethylene Glycol Dinitrate (EGDN) Nitroglycerin (NG) Method No.: 43 Matrix: Air OSHA PEL: EGDN And/Or NG
  • How to Use Your Nitroglycerin
  • PETN – Nitropenta: by Marcel Alcaraz Janßen, Mark-Oliver Baum, Simon Bechtel and Julian Baranyai
  • A Statement on the Use of Sildenafil in the Management of Sexual Dysfunction in Patients with Cardiovascular Disease
  • Serendipity in Discovery: from Nitric Oxide to Viagra1
  • Petn) (Casrn 78-11-5)
  • PRESCRIBING INFORMATION NITROSTAT® Nitroglycerin Sublingual Tablets USP 0.3 Mg, 0.6 Mg VASODILATOR Upjohn Canada ULC 17300
  • Beyond Discoverydiscoverytm
  • ETHYLENE GLYCOL DINITRATE See NITROGLYCERINE (Method 2507) for Procedure
  • Nitroglycerin | Memorial Sloan Kettering Cancer Center
  • List/Code of Hazardous Materials


© 2024 Docslib.org    Feedback